Starpharma's relationship with DNT links it into a much larger intellectual property space, as Tomalia retains many dendrimer-related patents.
FORBES: New Nano Protection Against HIV And Herpes
2.
Starpharma holds 33% equity in the U.S.-based privately--held Dendritic Nanotechnologies Inc. (DNT), which Raff, who is a molecular biologist, co-founded with chemist Donald Tomalia.
FORBES: New Nano Protection Against HIV And Herpes